Budesonide versus prednisone in the treatment of active Crohn's disease

Gastroenterology

Volumn 115, Issue 4, 1998, Pages 835-840

  Bar Meir, S ^a   Chowers, Y ^a   Lavy, A ^a   Abramovitch, D ^a   Sternberg, A ^a   Leichtmann, G ^a   Reshef, R ^a   Odes, S ^a   Moshkovitz, M ^a   Bruck, R ^a   Eliakim, R ^a   Maoz, E ^a   Mittmann, U ^a   Scapa, E ^a   Avidan, B ^a   Bardan, E ^a   Melzer, E ^a   Lang, A ^a   Safadi, R ^a   Goldin, E ^a   Coscas, E ^a   Fireman, Z ^a   Keter, D ^a   Liethman, G ^a   Maor, Y ^a   Naftali, T ^a   Kasem, G ^a   Jacobson, W ^a   Morali, G ^a   Zilberman, S ^a   Halpern, Z ^a   Shirin, C ^a   Wardi, Y ^a   more..

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; CORTICOSTEROID; PREDNISONE;

ACNE; ADULT; ARTICLE; CLINICAL TRIAL; COLITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROHN DISEASE; DOUBLE BLIND PROCEDURE; DRUG INDUCED DISEASE; FEMALE; HIRSUTISM; HUMAN; MAJOR CLINICAL STUDY; MALE; MOON FACE; MUSCLE WEAKNESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STEROID THERAPY; TREATMENT OUTCOME;

EID: 0031685585     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(98)70254-9     Document Type: Article

References (15)

1. A Kornbluth P Solomon DB Sachar Crohn's disease 6th ed M Slelsinger JS Fordtran Gastrointestinal disease 1993 Saunders Philadelphia 1273
2. H Malchow K Ewe JW Brandes H Goebel H Elms H Sommer H Jesdinsky European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment Gastroenterology 86 1984 249 266
3. RW Summers DM Switz JT Session Jr JM Becktel WR Best F Kern Jr JW Singleton National Cooperative Crohn's Disease Study: results of drug treatment Gastroenterology 77 1979 847 869
4. CM Spencer D McTavish Budesonide. A review of its pharmacological properties and therapeutic efficacy in inflammatory bowel disease Drugs 50 1995 854 872
5. R Brattsand Overview of newer glucocorticosteroid preparations for inflammatory bowel disease Can J Gastroenterol 4 1990 407 414
6. GR Greenberg BG Feagan F Martin LR Sutherland ABR Thomson CN Williams L-G Nilsson T Persson Oral budesonide for active Crohn's disease N Engl J Med 331 1994 836 841
7. P Rutgeerts R Lofberg H Malchow C Lamers G Olaison D Jewell A Danielsson H Goebell OO Thomsen H Lorenz-Meyer H Hodgson T Persson C Seidegard A comparison of budesonide with prednisolone for active Crohn's disease N Engl J Med 331 1994 842 845
8. WR Best JM Becktel JW Singleton F Kern Jr Development of a Crohn's disease activity index Gastroenterology 70 1976 439 444
9. M Campieri A Ferguson W Doe T Persson LG Nilsson Oral budesonide is as effective as oral prednisone in active Crohn's disease Gut 41 1997 209 214
10. M Nilsson S Edsbacker P Larsson JE Wiren Dose-proportional kinetics of budesonide controlled ileal release capsules (abstr) Gastroenterology 108 1995 A885
11. A Tromm HW Mollmann SV Heymann J Barth B May G Hochhaus H Derendorf Pharmacokinetics and dynamics after application of budesonide pH-modified-release-capsules in patients with Crohn's disease and healthy volunteers (abstr) Eur J Clin Pharmacol 50 1996 556
12. HW Mollmann G Hochhaus A Tromm P Froehlich AC Mollmann M Krieg H Weisser H Derendorf J Barth Pharmacokinetics and pharmacodynamics of budesonide pH-modified release capsules International Falk Workshop MA Norwell Kluwer 1996 107 120
13. S Edsbacker P Wollmer A Nilsson M Nilsson Pharmacokinetics and gastrointestinal transit of budesonide controlled ileal release (CIR) capsules (abstr) Gastroenterology 104 1993 A178
14. I Caesar V Gross M Roth T Andus C Schmidt R Raedsch A Weber M Gierend K Ewe J Scholmerich Treatment of active and post active ileal and colonic Crohn's disease with oral pH-modified-release budesonide Hepatogastroenterology 44 1997 445 451
15. V Gross T Andus I Caesar SC Bischoff H Lochs A Tromm H-J Schulz U Bar A Weber M Gierend K Ewe J Scholmerich Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease Eur J Gastroenterol Hepatol 8 1996 905 909